Difficulty: Medium
Average Score: 69%
Practice
A 43-year-old woman with a history of fibromyalgia and depression presents to her primary care physician for treatment. She complains of feeling sad and worthless in addition to multiple somatic complaints. Which of the following treatments would be best for this patient?
Correct answer
A
Rationale
In this scenario, the best treatment for the 43-year-old woman with fibromyalgia, depression, and somatic complaints would be Duloxetine (Option A). Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that is effective in treating both depression and chronic pain conditions like fibromyalgia.
Fluoxetine (Option B) is a selective serotonin reuptake inhibitor (SSRI) commonly used for depression but may not be as effective for managing both depression and chronic pain symptoms simultaneously. Mirtazapine (Option C) is a noradrenergic and specific serotonergic antidepressant (NaSSA) that is more commonly used for depression with insomnia or poor appetite, and may not be the best choice for a patient with fibromyalgia and somatic complaints. Sertraline (Option D) is another SSRI that may help with depression but lacks the dual mechanism of action that Duloxetine offers for managing both depression and chronic pain symptoms.
Educationally, understanding the different classes of antidepressants and their mechanisms of action is crucial in selecting the most appropriate treatment for patients with complex presentations like fibromyalgia and depression. It is essential to consider not only the mental health aspect but also the physical symptoms when choosing pharmacological interventions, hence making Duloxetine the most suitable option in this case.
Fluoxetine (Option B) is a selective serotonin reuptake inhibitor (SSRI) commonly used for depression but may not be as effective for managing both depression and chronic pain symptoms simultaneously. Mirtazapine (Option C) is a noradrenergic and specific serotonergic antidepressant (NaSSA) that is more commonly used for depression with insomnia or poor appetite, and may not be the best choice for a patient with fibromyalgia and somatic complaints. Sertraline (Option D) is another SSRI that may help with depression but lacks the dual mechanism of action that Duloxetine offers for managing both depression and chronic pain symptoms.
Educationally, understanding the different classes of antidepressants and their mechanisms of action is crucial in selecting the most appropriate treatment for patients with complex presentations like fibromyalgia and depression. It is essential to consider not only the mental health aspect but also the physical symptoms when choosing pharmacological interventions, hence making Duloxetine the most suitable option in this case.